Ophthalmology Department, 243586Baruch Padeh Medical Center, Poriya, Israel.
Affilitated to the Faculty of Medicine, Bar Ilan University, Israel.
Eur J Ophthalmol. 2022 Nov;32(6):3340-3345. doi: 10.1177/11206721221076941. Epub 2022 Feb 1.
To assess the success rate and complications of Lacrijet monocanalicular stent (FCI S.A.S, Paris, France) intubation in children treated for congenital nasolacrimal duct obstruction (CNLDO).
Retrospective review study which included children with CNLDO that were intubated with Lacrijet monocanalucilar silicone tube.The Lacrijet tube remained in place for 11-15 weeks post operatively and was removed in the clinic with topical anesthesia. Operative time was recorded for each case. All children were evaluated using the following parameters preoperatively and postoperatively: tear meniscus height, Fluorescein dye disappearance test (FDDT), and MUNK score.
The study included 20 eyes with mean age of 26.25 ± 11.25 months. 17 eyes (85%) had undergone probing previously. Mean operation time of Lacrijet intubation was 8.5 min (95% CI 7.04-9.95). Mean follow-up period was 204.65 ± 105.27 days. Lacrijet intubation resulted in statistically significant improvements in tear meniscus height ( < .001), FDDT ( < 0.001), and MUNK score ( < 0.001) in all children. Two different sizes of Lacrijet intubations were used. Complete success was obtained in all cases. No complications were observed.
Lacrijet lacrimal intubation has a high rate of success, shortens surgical time and has a low rate of complications in children with CNLDO.
评估 Lacrijet 单通道支架（法国巴黎 FCI S.A.S）在治疗先天性鼻泪管阻塞（CNLDO）儿童中的插管成功率和并发症。
回顾性研究，纳入接受 Lacrijet 单通道硅酮管插管治疗的 CNLDO 儿童。术后 Lacrijet 管留置 11-15 周，在局麻下于诊所取出。记录每例手术时间。所有患儿均于术前和术后采用以下参数进行评估：泪膜高度、荧光素染料消失试验（FDDT）和 MUNK 评分。
研究纳入 20 只眼，平均年龄为 26.25±11.25 个月。17 只眼（85%）曾行探通术。 Lacrijet 插管的平均手术时间为 8.5 分钟（95%CI 7.04-9.95）。平均随访时间为 204.65±105.27 天。 Lacrijet 插管在所有患儿中均使泪膜高度（ < 0.001）、FDDT（ < 0.001）和 MUNK 评分（ < 0.001）得到统计学显著改善。使用了两种不同尺寸的 Lacrijet 插管。所有病例均获得完全成功。未观察到并发症。
Lacrijet 泪道插管在 CNLDO 儿童中成功率高、手术时间短、并发症发生率低。
